A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC	Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, neoplasm	Recruiting	Phase 2	2022-05-11		NCT05182944

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
The First Affiliated Hospital of Zhengzhou University	203

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	125

Clinical trials